• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部前列腺素E水平的变化:治疗反应性的一个潜在因素?

Variations in local PGE levels: a potential factor in therapeutic responsiveness?

作者信息

Hammerman C, Arcilla R, Bui K C

机构信息

Department of Pediatrics, University of Chicago Medical Center, Illinois.

出版信息

Pediatr Cardiol. 1991 Apr;12(2):74-7. doi: 10.1007/BF02238406.

DOI:10.1007/BF02238406
PMID:1866341
Abstract

It was hypothesized that it is the concentration of PGE in the plasma which actually reaches the ductus arteriosus which determines ductal response to PGE administration. Therefore, site specific PGE levels were studied in two infants with ductus dependent congenital heart lesions who were receiving PGE1 infusions. PGE levels were found to vary in a fashion related to the infusion site and the specific cardiac anatomy and hemodynamics of each patient. One of our patients, for instance, had a double outlet right ventricle with high pulmonary vascular resistance and right to left ductal shunting. This infant was given an intraarterial infusion of PGE. The plasma concentrations of PGE in the ductal blood of the infant were negligible. Assuming that ductal site specific PGE levels are critical in mediating the therapeutic response, hemodynamics and infusion site are factors that should be considered when initiating a PGE infusion, or in evaluating a therapeutic failure of PGE.

摘要

据推测,实际上到达动脉导管的血浆中PGE的浓度决定了导管对PGE给药的反应。因此,对两名患有依赖动脉导管的先天性心脏病变且正在接受PGE1输注的婴儿进行了特定部位PGE水平的研究。发现PGE水平的变化方式与输注部位以及每位患者的特定心脏解剖结构和血流动力学有关。例如,我们的一名患者有右心室双出口,伴有高肺血管阻力和右向左导管分流。该婴儿接受了动脉内PGE输注。该婴儿导管血中PGE的血浆浓度可忽略不计。假设导管特定部位的PGE水平在介导治疗反应中至关重要,那么在开始PGE输注或评估PGE治疗失败时,血流动力学和输注部位是应考虑的因素。

相似文献

1
Variations in local PGE levels: a potential factor in therapeutic responsiveness?局部前列腺素E水平的变化:治疗反应性的一个潜在因素?
Pediatr Cardiol. 1991 Apr;12(2):74-7. doi: 10.1007/BF02238406.
2
Prostaglandin E1 in infants with congenital heart disease: Indian experience.先天性心脏病患儿使用前列腺素E1:印度的经验
Indian Pediatr. 1998 Nov;35(11):1063-9.
3
Nursing care of the neonate receiving prostaglandin E1 therapy.接受前列腺素E1治疗的新生儿的护理
Neonatal Netw. 1993 Jun;12(4):17-22.
4
Expression of prostanoid receptors in human ductus arteriosus.前列腺素受体在人类动脉导管中的表达。
Br J Pharmacol. 2003 Feb;138(4):655-9. doi: 10.1038/sj.bjp.0705092.
5
Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease.先天性心脏病婴儿使用前列腺素E1进行动脉导管的药物性扩张。
South Med J. 1978 Oct;71(10):1238-41, 1246. doi: 10.1097/00007611-197810000-00015.
6
Prostaglandin E1 treatment of congenital heart disease: use prior to neonatal transport.前列腺素E1治疗先天性心脏病:新生儿转运前的应用。
DICP. 1991 Apr;25(4):408-9. doi: 10.1177/106002809102500413.
7
Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.前列腺素E1用于维持患有动脉导管依赖性心脏病变的新生儿的动脉导管通畅。
Cochrane Database Syst Rev. 2018 Feb 27;2(2):CD011417. doi: 10.1002/14651858.CD011417.pub2.
8
[Effect of prostaglandin E1 on the hemodynamics in newborn infants with pulmonary atresia (author's transl)].
Z Kardiol. 1978 Aug;67(8):572-7.
9
Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.口服前列腺素E1衍生物(OP - 1206)用于一名患有右心室双出口及肺动脉狭窄的婴儿。对依赖动脉导管的肺循环的影响。
Jpn Heart J. 1991 Sep;32(5):735-40. doi: 10.1536/ihj.32.735.
10
[Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].[前列腺素治疗依赖动脉导管循环的新生儿]
Tijdschr Kindergeneeskd. 1985 Feb;53(1):20-5.

本文引用的文献

1
Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.患有动脉导管依赖性先天性心脏病的前列腺素E1婴儿。
Circulation. 1981 Nov;64(5):899-905. doi: 10.1161/01.cir.64.5.899.
2
Failure of clinical response to prostaglandin E1 in a cyanotic infant with congenital absence of the ductus arteriosus.
Cathet Cardiovasc Diagn. 1982;8(3):273-6. doi: 10.1002/ccd.1810080310.
3
Administration of E-type prostaglandins in ductus-dependent congenital heart disease.E型前列腺素在依赖动脉导管的先天性心脏病中的应用。
Pediatr Cardiol. 1982;2(4):303-5. doi: 10.1007/BF02426977.
4
Hypoxic vs septic pulmonary hypertension. Selective role of thromboxane mediation.
Am J Dis Child. 1988 Mar;142(3):319-25. doi: 10.1001/archpedi.1988.02150030093030.
5
Differential in vivo pulmonary degradation of prostaglandins E1, B1, and A1.前列腺素E1、B1和A1在体内的肺降解差异。
Am J Physiol. 1975 Jan;228(1):68-70. doi: 10.1152/ajplegacy.1975.228.1.68.
6
Role of prostaglandin E1 and E2 in the management of neonatal heart disease.前列腺素E1和E2在新生儿心脏病治疗中的作用。
Adv Prostaglandin Thromboxane Res. 1978;4:345-53.
7
E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.E型前列腺素:治疗某些青紫型先天性心脏畸形的一种新的急救疗法。
Circulation. 1976 Apr;53(4):728-31. doi: 10.1161/01.cir.53.4.728.